Skip to main content
Contact Us
Subscribe
E-Edition
74°
Site search
Search
Menu
Open user controls
Log In Using Your Account
Log In
Don't have an account?
Sign Up Today
My Account
Dashboard
Profile
Saved items
Logout
Home
About Us
Contact Us
Advertise
Terms and Conditions
Privacy Policy
Home Delivery
Subscription Services
Place an Ad
Promote Your Event
Local Weather
News
Sports
Obits
Multimedia
Photo Galleries
Videos
e-Edition
Classifieds
Real Estate
Property For Rent
Cars & Vehicles
Jobs
Items For Sale
Pets
Auctions, Estate & Garage Sales
Services
Community
Personals
Place An Ad
Subscribe
Archives
Best of 2025
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Kymera Therapeutics, Inc. - Common Stock
(NQ:
KYMR
)
43.58
UNCHANGED
Streaming Delayed Price
Updated: 4:00 PM EDT, Jun 3, 2025
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Kymera Therapeutics, Inc. - Common Stock
< Previous
1
2
3
4
5
Next >
Signet Posts Upbeat Earnings, Joins Ferguson Enterprises, Dollar General And Other Big Stocks Moving Higher On Tuesday
June 03, 2025
Via
Benzinga
Disney To Rally Around 24%? Here Are 10 Top Analyst Forecasts For Tuesday
June 03, 2025
Via
Benzinga
What 6 Analyst Ratings Have To Say About Kymera Therapeutics
June 03, 2025
Via
Benzinga
Kymera Therapeutics Soars After Multiple Analyst Upgrades; Retail Sentiment Turns Extremely Bullish
June 02, 2025
Morgan Stanley, BofA, and Citi upgraded the stock, citing strong safety, biomarker, and degradation data for its STAT6 degrader KT-621.
Via
Stocktwits
What's Next: Kymera Therapeutics's Earnings Preview
May 08, 2025
Via
Benzinga
Demystifying Kymera Therapeutics: Insights From 6 Analyst Reviews
February 28, 2025
Via
Benzinga
Earnings Scheduled For February 27, 2025
February 27, 2025
Via
Benzinga
The Latest Analyst Ratings For Kymera Therapeutics
November 01, 2024
Via
Benzinga
Here are the top movers in Monday's session.
June 02, 2025
Wondering how the US markets performed one hour before the close of the markets on Monday? Discover the movers and shakers of today's session in our comprehensive analysis.
Via
Chartmill
Which stocks are experiencing notable movement on Monday?
June 02, 2025
Wondering how the US markets performed in the middle of the day on Monday? Discover the movers and shakers of today's session in our comprehensive analysis.
Via
Chartmill
Vera Therapeutics, Applied Digital, Kymera Therapeutics And Other Big Stocks Moving Higher On Monday
June 02, 2025
Via
Benzinga
Preview: Kymera Therapeutics's Earnings
October 30, 2024
Via
Benzinga
Insights Ahead: Kymera Therapeutics's Quarterly Earnings
October 30, 2024
Via
Benzinga
The Analyst Landscape: 7 Takes On Kymera Therapeutics
September 27, 2024
Via
Benzinga
Cracking The Code: Understanding Analyst Reviews For Kymera Therapeutics
September 09, 2024
Via
Benzinga
Kymera Therapeutics Says Atopic Dermatitis Potential Matches Sanofi/Regeneron's Blockbuster Dupixent In Early Biomarker Response
June 02, 2025
Kymera's KT-621 achieved rapid, deep STAT6 degradation and showed a strong safety profile in Phase 1, with the next trials planned through early 2026.
Via
Benzinga
These stocks that are showing activity before the opening bell on Monday.
June 02, 2025
Let's have a look at what is happening on the US markets before the opening bell on Monday. Below you can find the top gainers and losers in today's pre-market session.
Via
Chartmill
12 Health Care Stocks Moving In Monday's Pre-Market Session
June 02, 2025
Via
Benzinga
12 Health Care Stocks Moving In Friday's After-Market Session
May 30, 2025
Via
Benzinga
Unveiling 6 Analyst Insights On Kymera Therapeutics
August 12, 2024
Via
Benzinga
Why Kymera Therapeutics Stock Is Soaring Today
July 09, 2024
Kymera's lead pipeline candidate received some good news.
Via
The Motley Fool
Friday's after hours session: top gainers and losers
May 30, 2025
After the closing bell on Friday, let's take a glimpse of the US markets and explore the top gainers and losers in today's after-hours session.
Via
Chartmill
The Analyst Verdict: Kymera Therapeutics In The Eyes Of 4 Experts
May 12, 2025
Via
Benzinga
Earnings Scheduled For May 9, 2025
May 09, 2025
Via
Benzinga
Bitdeer Tech And Tempus AI Are Among Top 18 Mid-Cap Gainers Last Week (Apr 21-Apr 25): Are The Others In Your Portfolio?
April 27, 2025
Top mid-cap stock performers last week: Ascentage Pharma, Ardagh Metal, Bitdeer Tech, Pegasystems, Impinj, Lufax, Tempus AI, Kymera Therapeutics.
Via
Benzinga
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
Why Kymera Therapeutics Stock Crushed it This Week
April 25, 2025
Via
The Motley Fool
Positive Outlook For Novartis As Company Capitalizes On Growing Treatment Opportunities, Analyst Highlights
October 30, 2024
Novartis aims to enhance Pluvicto's market presence while exploring growth in multiple sclerosis and expanding its radioligand therapy portfolio.
Via
Benzinga
This BJ's Wholesale Analyst Is No Longer Bearish; Here Are Top 5 Upgrades For Monday
August 26, 2024
Via
Benzinga
XPeng & QuantumScape Are Among Top 11 Mid Cap Stocks That Performed Well Last Week (July 7-July 13): Details
July 14, 2024
10 mid-cap stocks jumped in last week, including QuantumScape, Lantheus Holdings, Sunrun, Kymera Therapeutics, Apogee Therapeutics, Joby Aviation, Crinetics Pharmaceuticals, Dyne Therapeutics, Summit...
Via
Benzinga
Why Helen of Troy Shares Are Trading Lower By Around 30%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
July 09, 2024
Via
Benzinga
< Previous
1
2
3
4
5
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms Of Service
.
